PPT-Switching between coagulation factors

and Immunogenicity Peyman Eshghi Prof of Pediatric Hematology ampOncology Pediatric Congenital Hematologic Disorders Research Center Mofid Children Hospital Shahid Beheshti University of Medical sciences. Abnormalities of Blood Coagulation. Learning Objectives. Describe functions of blood vessels and platelets in controlling bleeding. Explain three phases of coagulation and the respective factors involved. I-. Deficiency of Coagulation Factors. II-. HYPERCOAGULABLE STATES . I-. Deficiency of Coagulation Factors. Treatment. AQUIRED DISORDERS. OF. BLOOD COAGULATION. ACQUIRED DISORDERS. OF. BLOOD COAGULATION. I-. Deficiency of Coagulation Factors. II-. HYPERCOAGULABLE STATES . I-. Deficiency of Coagulation Factors. Treatment. AQUIRED DISORDERS. OF. BLOOD COAGULATION. ACQUIRED DISORDERS. OF. BLOOD COAGULATION. Acquired coagulation disorders:. They are . more common. than the inherited disorders. Unlike the inherited disorders, . multiple clotting. factor deficiencies are usual.. The acquired coagulation disorders.. Acquired coagulation disorders:. They are . more common. than the inherited disorders. Unlike the inherited disorders, . multiple clotting. factor deficiencies are usual.. The acquired coagulation disorders.. Guy Young, MD. Children’s Hospital Los Angeles. University of Southern California Keck School of Medicine. Abbreviations. Abbreviations will be explained the first time the term appears on a slide. “. The actors and forces outside marketing that affect marketing mgt’s ability to build and maintain successful relationships with target customers” – . Kotler. . Today's markets change rapidly and marketers need to adopt their strategies and to meet new challenges and opportunities. banking. Stefano Callari, Alexander Moore, Laura . Rovegno . Competition and Markets Authority. †. . Pasquale . Schiraldi. . London School of Economics. 1. †. . Although the authors worked on certain aspects of the retail banking market investigation at the UK Competition and Markets Authority (CMA), the views and opinions expressed in this paper are the sole responsibility of the authors and do not necessarily reflect those of the CMA or the inquiry group. . Edin. ). Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following vascular injury in order to prevent excessive bleeding, a process known as haemostasis. It is localised to the tissue damage and is followed by removal of the clot and tissue damage.. Mehran Karimi MD. Tehran, September 14, 2017. Agenda. Background. Causes of bleeding and Clinical manifestations. Classification of coagulation disorders in neonates. Primary investigation and diagnostic evaluation. M. AND J. E. WYNANDS, M.D., C.IVI.~ THE V~Y F_~aLY STUVmS of this subject, many controversies existed regard- ing the various factors and mechanisms involved in the dotting process. One simply has to and . congestion. both. . refer. to an . increase. in . blood. volume . within. a . tissue. , . but. . have. . different. . underlying. . mechanisms. .. Hyperemia. . is. . an. . active. . . Classify drugs acting as anticoagulants. . Elaborate on their mechanism of action, correlating that with methods of monitoring. . Contrast the limitations & benefits of injectable anticoagulants in clinical settings. The stoppage of . bleeding. or . hemorrhage. The normal . haemostatic. response; . to vascular damage depends on a closely linked interaction between the . blood vessel wall. , . circulating platelets.